SA
MDT icon

Sicart Associates’s Medtronic MDT Stock Holding History

Sicart Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63M Sell
71,922
-665
-0.9% -$53.6K 1.38% 26
2026
Q1 		$6.29M Hold
72,587
– – 1.62% 24
2025
Q4 		$6.97M Sell
72,587
-140
-0.2% -$13.6K 1.85% 18
2025
Q3 		$6.93M Sell
72,727
-15
-0% -$1.38K 1.88% 19
2025
Q2 		$6.34M Sell
72,742
-2,548
-3% -$216K 2.22% 18
2025
Q1 		$6.82M Sell
75,290
-150
-0.2% -$13.4K 2.36% 15
2024
Q4 		$6.08M Sell
75,440
-3,020
-4% -$261K 2.17% 21
2024
Q3 		$7.12M Buy
78,460
+75
+0.1% +$6.31K 2.5% 15
2024
Q2 		$6.22M Sell
78,385
-1,387
-2% -$114K 2.39% 18
2024
Q1 		$7.01M Sell
79,772
-1,489
-2% -$127K 2.57% 17
2023
Q4 		$6.75M Sell
81,261
-2,777
-3% -$212K 2.58% 15
2023
Q3 		$6.64M Buy
84,038
+348
+0.4% +$29.1K 2.61% 14
2023
Q2 		$7.38M Buy
83,690
+69,610
+494% +$5.99M 2.87% 13
2023
Q1 		$1.14M Sell
14,080
-2,611
-16% -$213K 0.45% 43
2022
Q4 		$1.31M Sell
16,691
-3,615
-18% -$293K 0.46% 44
2022
Q3 		$1.65M Sell
20,306
-3,145
-13% -$283K 0.59% 38
2022
Q2 		$2.12M Buy
23,451
+953
+4% +$96.6K 0.66% 38
2022
Q1 		$2.51M Sell
22,498
-2,110
-9% -$223K 0.65% 38
2021
Q4 		$2.59M Sell
24,608
-919
-4% -$106K 0.67% 36
2021
Q3 		$3.22M Sell
25,527
-1,325
-5% -$171K 0.88% 33
2021
Q2 		$3.35M Sell
26,852
-350
-1% -$43.9K 0.8% 33
2021
Q1 		$3.23M Sell
27,202
-1,176
-4% -$138K 0.85% 31
2020
Q4 		$3.34M Buy
28,378
+4,730
+20% +$521K 0.83% 31
2020
Q3 		$2.47M Sell
23,648
-210
-0.9% -$21.1K 0.74% 34
2020
Q2 		$2.2M Buy
+23,858
New +$2.29M 0.7% 37

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sicart Associates's MDT Position: Q2 2026 in Review

Sicart Associates reduced its Medtronic (MDT) stake by 0.92% in Q2 2026, selling an estimated $53.6K and leaving 71,922 shares worth $5.63M. The position accounts for 1.38% of the portfolio, ranked #26.

Sicart Associates first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.38M in Q2 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sicart Associates held 71,922 shares of Medtronic worth $5.63M as of Q2 2026.
  • Sicart Associates sold 665 Medtronic shares in Q2 2026, an estimated $53.6K.
  • Medtronic made up 1.38% of Sicart Associates's portfolio in Q2 2026, its #26 holding.
  • Sicart Associates first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
  • Sicart Associates's Medtronic position peaked at $7.38M in Q2 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sicart Associates's 13F filing for Q2 2026, filed 11 Aug 2026.